‹ All Posts
Sneha Jain

4th Aug 2025 · SEBI-Registered Analyst

GRANULES INDIA

USFDA ISSUES FORM 483 WITH 1 OBSERVATION • Facility: Granules Life Sciences Private Limited, wholly owned subsidiary located in Shamirpet Mandal, Hyderabad. • Regulatory Update: Received Form 483 from USFDA with 1 observation. • Impact: Minor observation; company expected to address it promptly.

GRANULES

#WatchOutFor
1,027 likes·48 comments